Sat.Jul 11, 2020 - Fri.Jul 17, 2020

article thumbnail

Common Drugs with Effective Off-Label Uses

Drug Patent Watch

This article was originally published by Mohammed M. Alshehri and Mahmoud M. E. Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…. The post Common Drugs with Effective Off-Label Uses appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Cariflex to Double its Polyisoprene Latex Capacity at the Paulinia Facility in Brazil

Pharma Mirror

Cariflex PTE. Ltd. (Cariflex) announced that it will be constructing a new large-scale polyisoprene latex plant at its Paulinia, Brazil, facility to meet the strong market demand from its medical and consumer product customers. Cariflex is excited to be making a sizeable investment in the growth of the polyisoprene latex business. Cariflex polyisoprene latex is.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Walgreens and CVS Top the 28,000 Pharmacies Profiting from the 340B Program. Will the Unregulated Party End?

Drug Channels

It’s time for our annual look at the 340B Drug Pricing Program’s booming pharmacy component. Our exclusive analysis of government data finds that 28,000 pharmacy locations—almost half of the U.S. industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program. Over the past 12 months, the number of pharmacies in the program has grown by more than 3,300 locations.

article thumbnail

NCLEX: What to Know Before Taking the Exam

Board Vitals - Pharmacist

The National Council Licensure Examination ( NCLEX® ), is used by all state nursing boards to determine whether or not a nurse is ready to practice at an entry-level. There are two NCLEX examinations, the NCLEX-PN® , for practical and vocational nurses, and the NCLEX-RN® , for registered nurses. Although many concepts are overlapping, this post will solely discuss the NCLEX-RN® for the sake of simplicity.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

A comprehensive review of database resources in chemistry

Drug Patent Watch

This article was originally published by Syed Sauban Ghani in Eclética Química under a Creative Commons license. ABSTRACT As scientific community worldwide is publishing a huge number of research articles…. The post A comprehensive review of database resources in chemistry appeared first on DrugPatentWatch - Make Better Decisions.

52
article thumbnail

Episode 522: Alternatives to ampicillin for empiric listeria coverage

Pharmacy Joe

In this episode, I’ll discuss alternatives to ampicillin for empiric listeria coverage. Episode 522: Alternatives to ampicillin for empiric listeria coverage Subscribe on iTunes , Android , or Stitcher Shout out to “Pharmacy Alex” for inspiring this episode. Bacterial meningitis treatment guidelines suggest adding ampicillin for empiric coverage against listeria in patients above age 50, and Swedish guidelines include this coverage for all adults.

More Trending

article thumbnail

Episode 521: Drug-induced liver injury in a COVID-19 patient – a remdesivir and PGP inhibitor interaction?

Pharmacy Joe

In this episode, I’ll discuss a case of drug-induced liver injury in a COVID-19 patient taking remdesivir and a PGP inhibitor. Episode 521: Drug-induced liver injury in a COVID-19 patient – a remdesivir and PGP inhibitor interaction? Subscribe on iTunes , Android , or Stitcher A case report of apparent drug-induced liver injury from remdesivir and PGP inhibitors was published in the journal Clinical Infectious Diseases in June 2020.

article thumbnail

SGLT2 Inhibitors Comparison Table – Clinical Application

Med Ed 101

Sodium-glucose co-transporter 2 inhibitors (SGLT2s) are becoming popular treatments for type 2 diabetes mellitus. While typically classified as diabetes medications, there is more and more research coming out for their benefits in cardiovascular health and heart failure. There are currently four SGLT2s on the market, all still available as brand-name only: canagliflozin (Invokana), dapagliflozin (Farxiga), […].